|Molar Mass||2645.1 g/mol|
Colivelin Vials represent a cutting-edge research product designed exclusively for research purposes, with strict adherence to non-human consumption. This unique peptide, Colivelin, is synthesized to the highest research standards and is intended to be employed in various scientific investigations. It is imperative to emphasize that Colivelin Vials are not for human use.
Colivelin is a novel peptide with distinctive characteristics, including its stability and ability to penetrate cell membranes efficiently. This allows researchers to explore its potential applications in diverse experimental settings.
Colivelin Vials find application in a range of research studies, leveraging the peptide’s unique properties for various experimental contexts.
Colivelin for Spinal Cord Injury
Colivelin demonstrates promise in spinal cord injury research. Studies have indicated its potential to promote neuronal survival, reduce inflammation, and facilitating functional recovery after spinal cord injury.
Colivelin for Alzheimer’s Disease
In Alzheimer’s Disease research, Colivelin shows promise in attenuating neurodegeneration. Studies propose that the peptide may have neuroprotective and anti-apoptotic effects, offering a potential avenue for further exploration in Alzheimer’s research.
Colivelin Peptide for ALS Treatment
Research suggests that Colivelin exhibits neuroprotective effects, making it a candidate for Amyotrophic Lateral Sclerosis (ALS) investigations. The peptide’s ability to mitigate oxidative stress and enhance cell survival may contribute to potential therapeutic avenues.
Colivelin Vials represent a valuable tool for researchers delving into neurological and neurodegenerative disorders. Its unique characteristics and demonstrated benefits in spinal cord injury, ALS treatment, and Alzheimer’s research underscore its potential as a crucial asset in advancing scientific understanding in these areas. However, it is crucial to reiterate that Colivelin Vials are exclusively for research purposes and should not be used for human consumption. Researchers are encouraged to refer to the provided references for in-depth insights into the studies supporting these claims.
1. Wenbo Shao, Cunxin Zhang, Kang Li, Ziang Lu, Zihao Zhao, Kai Gao, Chaoliang Lv, Wogonin inhibits inflammation and apoptosis through STAT3 signal pathway to promote the recovery of spinal cord injury, Brain Research, Volume 1782, 2022, 147843, ISSN 0006-8993, https://doi.org/10.1016/j.brainres.2022.147843. [Read More]
2. Tomohiro Chiba, Marina Yamada, Jumpei Sasabe, Kenzo Terashita, Sadakazu Aiso, Masaaki Matsuoka, Ikuo Nishimoto, Colivelin prolongs survival of an ALS model mouse, Biochemical and Biophysical Research Communications, Volume 343, Issue 3, 2006, Pages 793-798, ISSN 0006-291X, https://doi.org/10.1016/j.bbrc.2006.02.184 [Read More]
3. Banek CT, Bauer AJ, Needham KM, Dreyer HC, Gilbert JS. AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat. Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1159-65. doi: 10.1152/ajpheart.00903.2012. Epub 2013 Feb 15. PMID: 23417865; PMCID: PMC3625906. [Read More]